DCF — MARSHFIELD MEDICAL CENTER
Enterprise Value: $-1.5B
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-1.5B
Enterprise Value
$-479.8M
PV of Cash Flows
$-1.1B
PV of Terminal Value
$-1.7B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $788.7M | $-98.8M | -13.0% | $-132.2M | $-120.1M |
| Year 2 | $812.4M | $-93.6M | -12.0% | $-128.0M | $-105.8M |
| Year 3 | $836.7M | $-88.0M | -11.0% | $-123.5M | $-92.8M |
| Year 4 | $861.8M | $-86.4M | -10.0% | $-122.9M | $-83.9M |
| Year 5 | $887.7M | $-86.8M | -10.0% | $-124.3M | $-77.2M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-1.5B. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$765.7M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.1302292300438255
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5